Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 62,870 | 36,741 | 30,259 | 18,143 | 16,113 |
| Depreciation Amortization | 35,335 | 32,453 | 18,958 | 11,197 | 9,355 |
| Income taxes - deferred | 3,464 | 16,493 | 13,858 | 3,383 | 20,188 |
| Accounts receivable | -64,351 | 21,405 | 35,456 | -21,890 | -34,873 |
| Accounts payable and accrued liabilities | 4,749 | -9,279 | -551 | 274 | 2,510 |
| Other Working Capital | -67,846 | 13,541 | 24,143 | -12,832 | -46,481 |
| Other Operating Activity | 68,296 | 964 | -25,155 | 41,368 | 45,373 |
| Operating Cash Flow | $42,517 | $112,318 | $96,968 | $39,643 | $12,185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,966 | 63 |
| PPE Investments | -44,812 | -30,673 | -42,021 | -42,080 | -54,026 |
| Net Acquisitions | -650 | -179,379 | -25,873 | N/A | N/A |
| Investing Cash Flow | $-45,462 | $-210,052 | $-67,894 | $-40,114 | $-53,963 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 242,588 | 62,000 | 13,547 | 27,522 |
| Debt Repayment | N/A | -62,000 | -62,774 | -10,227 | -15,494 |
| Common Stock Issued | 25,961 | 14,078 | 6,848 | 761 | 10,026 |
| Common Stock Repurchased | -100 | -200 | -213 | -5,906 | 0 |
| Other Financing Activity | 7,530 | 4,408 | 2,751 | 60 | -5,395 |
| Financing Cash Flow | $35,391 | $198,874 | $8,612 | $-1,765 | $16,659 |
| Exchange Rate Effect | -150 | 21 | -14 | 1 | 1 |
| Beginning Cash Position | 280,499 | 179,338 | 141,666 | 143,901 | 169,019 |
| End Cash Position | 312,795 | 280,499 | 179,338 | 141,666 | 143,901 |
| Net Cash Flow | $32,296 | $101,161 | $37,672 | $-2,235 | $-25,118 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,517 | 112,318 | 96,968 | 39,643 | 12,185 |
| Capital Expenditure | -44,812 | -30,673 | -42,021 | -53,845 | -54,026 |
| Free Cash Flow | -2,295 | 81,645 | 54,947 | -14,202 | -41,841 |